Primit Parikh - Feb 28, 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and COO
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Feb 28, 2022
Transactions value $
$4,340
Form type
4
Date filed
6/10/2022, 04:42 PM
Previous filing
Jan 4, 2022
Next filing
Aug 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Options Exercise $4.34K +1K +0.41% $4.34 246K Feb 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Options Exercise $0 -1K -1.21% $0.00 81.9K Feb 28, 2022 Common Stock 1K $4.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are fully vested and exercisable.